Coagulation profile of human COVID-19 convalescent plasma

Allan M. Klompas, Noud van Helmond, Justin E. Juskewitch, Rajiv K. Pruthi, Matthew A. Sexton, Juan C.Diaz Soto, Stephen A. Klassen, Katherine A. Senese, Camille M. van Buskirk, Jeffrey L. Winters, James R. Stubbs, Scott A. Hammel, Michael J. Joyner, Jonathon W. Senefeld

Research output: Contribution to journalArticlepeer-review


Convalescent plasma is used to treat COVID-19. There are theoretical concerns about the impact of pro-coagulant factors in convalescent plasma on the coagulation cascade particularly among patients with severe COVID-19. The aim of this study was to evaluate the coagulation profile of COVID-19 convalescent plasma. Clotting times and coagulation factor assays were compared between fresh frozen plasma, COVID-19 convalescent plasma, and pathogen-reduced COVID-19 convalescent plasma. Measurements included prothrombin time, activated partial thromboplastin time, thrombin time, fibrinogen, D-dimer, von Willebrand factor activity, von Willebrand factor antigen, coagulation factors II, V, VII–XII, protein S activity, protein C antigen, and alpha-2 plasmin inhibitor. Clotting times and coagulation factor assays were not different between COVID-19 convalescent plasma and fresh frozen plasma, except for protein C antigen. When compared to fresh frozen plasma and regular convalescent plasma, pathogen reduction treatment increased activated partial thromboplastin time and thrombin time, while reducing fibrinogen, coagulation factor II, V, VIII, IX, X, XI, XII, protein S activity, and alpha-2 plasmin inhibitor. The coagulation profiles of human COVID-19 convalescent plasma and standard fresh frozen plasma are not different. Pathogen reduced COVID-19 convalescent plasma is associated with reduction of coagulation factors and a slight prolongation of coagulation times, as anticipated. A key limitation of the study is that the COVID-19 disease course of the convalesced donors was not characterized.

Original languageEnglish (US)
Article number637
JournalScientific reports
Issue number1
StatePublished - Dec 2022
Externally publishedYes

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Coagulation profile of human COVID-19 convalescent plasma'. Together they form a unique fingerprint.

Cite this